Showing results (861-870 of 5,983) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|October 11, 2013
Molecular predictors of sensitivity to the insulin-like growth factor 1 receptor inhibitor Figitumumab (CP-751,871)Adam Pavlicek, Maruja E Lira, Nathan V Lee, et al.
Molecular Cancer Therapeutics|October 15, 2013
Inhibition of Wee1 sensitizes cancer cells to antimetabolite chemotherapeutics in vitro and in vivo, independent of p53 functionalityAnnemie A Van Linden, Dmitry Baturin, James B Ford, et al.
Molecular Cancer Therapeutics|December 18, 2013
Novel neutralizing hedgehog antibody MEDI-5304 exhibits antitumor activity by inhibiting paracrine hedgehog signalingNeil R Michaud, Youzhen Wang, Kristen A McEachern, et al.
Molecular Cancer Therapeutics|November 14, 2013
Low levels of circulating estrogen sensitize PTEN-null endometrial tumors to PARP inhibition in vivoDeanna M Janzen, Daniel Y Paik, Miguel A Rosales, et al.
Molecular Cancer Therapeutics|November 14, 2013
Response to MLN8237 in pancreatic cancer is not dependent on RalA phosphorylationNicole F Neel, Jeran K Stratford, Vaishali Shinde, et al.
Molecular Cancer Therapeutics|September 4, 2007
A platelet biomarker for assessing phosphoinositide 3-kinase inhibition during cancer chemotherapyRita K Bowers, Philip Marder, Lisa J Green, et al.
Molecular Cancer Therapeutics|September 4, 2007
The phosphatidylinositol 3-kinase inhibitor, PX-866, is a potent inhibitor of cancer cell motility and growth in three-dimensional culturesAmy L Howes, Gary G Chiang, Elizabeth S Lang, et al.
Molecular Cancer Therapeutics|June 3, 2010
Butein sensitizes human hepatoma cells to TRAIL-induced apoptosis via extracellular signal-regulated kinase/Sp1-dependent DR5 upregulation and NF-kappaB inactivationDong-Oh Moon, Mun-Ock Kim, Yung Hyun Choi, et al.
Molecular Cancer Therapeutics|April 29, 2010
Inhibition of the insulin-like growth factor I receptor by epigallocatechin gallate blocks proliferation and induces the death of Ewing tumor cellsHyung-Gyoo Kang, Jasmine M Jenabi, Xian Fang Liu, et al.
Molecular Cancer Therapeutics|May 27, 2010
Oncogenic functions of secreted Frizzled-related protein 2 in human renal cancerSoichiro Yamamura, Kazumori Kawakami, Hiroshi Hirata, et al.
Pageof 599